FGF21 and Menkes disease: In this regard, the data obtained from our three cohorts confirm the usefulness of both GDF15 and FGF21 for differentiating MD patients in adulthood, the former being the biomarker that best discriminates MD cases regardless of their genotype or clinical phenotype.